NUVASIVE INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2015 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Nuvasive Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q1 2023.
- Nuvasive Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was -$5.21M, a 33.9% decline year-over-year.
- Nuvasive Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$11M, a 165% decline from 2021.
- Nuvasive Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$4.14M, a 77% increase from 2020.
- Nuvasive Inc annual Deferred Income Tax Expense (Benefit) for 2020 was -$18M, a 408% decline from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)